Invited Speakers

*Alphabetical order by last name

Plenary 2
February 22 (Mon), 13:35-14:15

V. Narry Kim Korea

Seoul National University / IBS

Noncanonical Tails: Functions, Mechanisms, and Therapeutic Potential

Plenary 3
February 23 (Tue), 09:00-09:40

Jin-Soo Kim Korea

KAIST

Organellar DNA Editing in Vitro and in Vivo

Session 1
February 22 (Mon), 09:55-11:10

June Hyun Park Korea

OliX Pharmaceuticals

Expanding RNAi Therapeutics Beyond the Liver: An Integrated OASIS Platform for Hepatic and Extrahepatic Delivery



Session 2
February 22 (Mon), 11:30-12:35

Helen Cho Korea

Samyang Biopharm

Transforming Pulmonary Therapeutics with a Novel Lung-Selective Ionizable Lipid and Polymer-Based Stability Enhanced Nanoshell (SENSTM) Technology Optimized for Inhaled and Systemic Administrations

Young Jun Seo Korea

Elonova

Chemical Engineering of mRNA for Enhanced Translation and Therapeutic Performance



Session 3
February 22 (Mon), 14:15-15:35

Yoosik Kim Korea

KAIST

Decoding RNA-RBP Dynamics to Control RNA Immunogenicity

Jinha Yu Korea

Ewha Womans University

Synthesis and Biological Evaluation of 3′-C-Fluoromethyl-8-azaadenosine as a Novel Hit Targeting ADAR-Mediated RNA Editing



Session 4
February 22 (Mon), 15:55-17:25

Dae-Ro Ahn Korea

KIST

Extrahepatic Delivery of Oligonucleotide Therapeutics Using DNA Nanostructures

Kris S. Choi Korea

ST Pharm

Engineered Cysteine AOC Process Development: DAR Control, Orthogonal Analytics, and Site-Level Characterisation

Mahnseok Kye Korea

ST Pharm

Engineered Cysteine AOC Process Development: DAR Control, Orthogonal Analytics, and Site-Level Characterisation



Session 5
February 23 (Tue), 09:40-10:55

Seung Ryul Han Korea

Rznomics

TBD



Session 6
February 23 (Tue), 11:15-12:15

Hanna Suh Korea

Korea Institute of Toxicology

Enhancing Translational Validity: Integrating Welfare, Behavioral Enrichment, and the 3Rs into Non-Human Primate Models for Oligonucleotide Therapeutics Development



Session 7
February 23 (Tue), 13:15-15:15

Jeong Ho Lee Korea

KAIST / Sovargen

Brain Somatic Mosaicism: A Platform for RNA Therapeutic Target Discovery in Neurological Disorders

Il-Hoan Oh Korea

RegenInnopharm

TBD

TOP